DMC (US:BOOM)2026-02-23 21:16Financial Performance - Consolidated net sales were $609,840 in 2025, a decrease of 5% from $642,851 in 2024, primarily due to lower sales at DynaEnergetics and NobelClad[282]. - Consolidated gross profit margin decreased to 22.2% in 2025 from 23.4% in 2024, attributed to less favorable project and regional mix at NobelClad[287]. - DynaEnergetics experienced a 6% decrease in sales, largely due to lower pricing from industry consolidation, reducing net sales by $16,213[286]. - NobelClad's sales decreased by 11%, driven by lower activity levels impacted by evolving tariff policies throughout the year[286]. - DMC Global Inc. reported net sales of $609,840 for 2025, a decrease from $642,851 in 2024, with Arcadia Products contributing $246,208, DynaEnergetics $270,214, and NobelClad $93,418[304]. - Net loss attributable to DMC Global Inc. in 2025 was $13,452, or $(0.90) per diluted share, compared to a net loss of $94,452, or $(8.20) per diluted share in 2024[299]. - Operating income decreased to $10,362 in 2025 from $16,167 in 2024, primarily due to a reduction in gross profit[314]. - Adjusted EBITDA for 2025 decreased to $34,942 from $52,156 in 2024, reflecting a decline in overall performance[301]. - Adjusted EBITDA attributable to DMC Global Inc. was $34,942 in 2025, a decrease of 33% from $52,156 in 2024[286]. - Adjusted EBITDA decreased to $18,485 in 2025 from $24,803 in 2024, a decline of 25.6%[315]. Expenses and Costs - Selling and distribution expenses increased by $1,535 in 2025, driven by higher compensation costs and bad debt expense[288]. - General and administrative expenses for Arcadia Products decreased by $5,710 in 2025, mainly due to reduced compensation costs related to headcount reductions[306]. - General and administrative expenses increased by $870 in 2025, primarily due to a remediation liability of $698[317]. - Interest expense for 2025 was $6,493, a 25% decrease compared to 2024, attributed to lower outstanding balances on the credit facility[296]. - Strategic review and related expenses decreased to $2,690 in 2025 from $7,765 in 2024, primarily due to lower professional service fees and employee retention compensation[290]. - Restructuring expenses and asset impairments for 2025 totaled $3,578, including contract termination costs of $1,013 and employee severance of $1,175[292]. - Restructuring expenses and asset impairments totaled $1,224 in 2025, including contract termination costs of $1,013[318]. Debt and Cash Flow - Net debt decreased to $18,746 at December 31, 2025, down from $56,529 at December 31, 2024, due to voluntary credit facility repayments[282]. - The company's leverage ratio improved to 1.22x as of December 31, 2025, down from 1.35x in 2024, compared to a maximum permitted ratio of 3.0x[282]. - Cash flows from operating activities increased to $53,534 in 2025 from $46,596 in 2024, driven by lower working capital balances[334]. - The actual leverage ratio as of December 31, 2025, was 1.22 to 1.0, well below the maximum permitted ratio of 3.0 to 1.0[326]. - The debt service coverage ratio for the trailing twelve months ended December 31, 2025, was 3.28 to 1.0, exceeding the minimum requirement of 1.25 to 1.0[327]. - Net cash used in financing activities in 2025 amounted to $28,736 million, which included net credit facility repayments of $20,521 million and distributions to redeemable noncontrolling interest holders of $6,400 million[337]. - Net cash used in investing activities in 2025 was $6,564 million, primarily due to the acquisition of property, plant, and equipment totaling $10,731 million, offset by a note receivable settlement of $4,167 million[335]. Impairments and Valuation - The company recorded impairment charges of $1,081 million on property, plant, and equipment in 2025, mainly related to a $785 million charge for discontinuing an internal website and automation platform[345]. - As of December 31, 2025, the consolidated valuation allowance against deferred tax assets was $35,323 million, reflecting a three-year cumulative loss position driven by goodwill impairment in 2024[347]. Foreign Exchange and Risk - Sales in currencies other than U.S. dollars accounted for 10% of total sales in 2025, with the primary exposure to foreign currency risk being the Euro[351]. - The net notional amount of foreign exchange contracts at December 31, 2025, was $10,858 million, compared to $8,331 million in 2024[352]. - A one percentage point increase in average interest rates would increase interest expense by $700 million in 2025, given that all of the company's debt was subject to variable interest rates[353]. Order Backlog - Order backlog for NobelClad increased to $62,612 at the end of Q4 2025 from $57,040 at the end of Q3 2025, reflecting additional orders from a record international chemical project[281].